Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
An open study of long term treatment with an oral beta 2 agonist (pirbuterol 20 mg three times daily) was undertaken in 63 patients with severe chronic heart failure. During three months of treatment 20 (32%) patients died, of whom 16 were taking the drug at the time of death. Mortality was related...
Guardat en:
| Publicat a: | Br Heart J |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1983
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481410/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6137226/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.50.3.282 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|